A
Ana Barac
Researcher at Georgetown University
Publications - 158
Citations - 8236
Ana Barac is an academic researcher from Georgetown University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 30, co-authored 126 publications receiving 5347 citations. Previous affiliations of Ana Barac include MedStar Georgetown University Hospital & MedStar Washington Hospital Center.
Papers
More filters
Journal ArticleDOI
The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
TL;DR: In this paper, the authors discuss opportunities for primary prevention in patients with breast cancer at risk for cardiac dysfunction, focusing on cardiac dysfunction as the most wellstudied side effect during contemporary breast cancer treatment, in particular with the use of anthracyclines and/or trastuzumab.
Journal ArticleDOI
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.
Ana Barac,Hong Wang,Hong Wang,Nawar Shara,Nawar Shara,Giovanni de Simone,Elizabeth A. Carter,Elizabeth A. Carter,Jason G. Umans,Jason G. Umans,Lyle G. Best,Jeunliang Yeh,Damon B. Dixon,Richard B. Devereux,Barbara V. Howard,Barbara V. Howard,Julio A. Panza +16 more
TL;DR: In a population with a high prevalence of obesity, MS, and diabetes, elevated CRP and fibrinogen increased HF risk, but these associations are attenuated by the adjustments for conventional risk factors suggesting that inflammation acts in concert with metabolic and clinical risk factors in increasing HF risk.
Journal ArticleDOI
Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity.
Susan Dent,Robin Kikuchi,Lavanya Kondapalli,Roohi Ismail-Khan,Christine Brezden-Masley,Ana Barac,Michael G. Fradley +6 more
TL;DR: Practical advice on how to identify, monitor, and treat patients with cancer who are at risk for developing cancer treatment-related cardiovascular dysfunction is discussed and pharmacologic strategies to mitigate cardiovascular toxicity during and following completion of cancer therapy are reviewed.
Journal ArticleDOI
A Review of Genetics, Arterial Stiffness, and Blood Pressure in African Americans
TL;DR: The genetic findings to date in the area of arterial stiffness and blood pressure in African Americans are reviewed with an emphasis on the current limitations and new efforts to move the field forward.
Journal ArticleDOI
COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity
Robert A. Harrington,Ana Barac,John E. Brush,Joseph A. Hill,Harlan M. Krumholz,Michael S. Lauer,Chittur A. Sivaram,Mark B. Taubman,Jeffrey L. Williams +8 more
TL;DR: The writing committee was selected to represent the American College of Cardiology and included a cardiovascular training program director, several active cardiovascular scientists and research methodology.